Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.

Hepatitis C virus (HCV) is the major cause of liver ... there is an increasingly large number of competitive protease inhibitors in development — for example, boceprevir (Schering–Plough ...

while the potential high-risk toxicity of HCV protease inhibitors needs to be further evaluated in HIV–HCV-coinfected patients. In general, HAART should first be initiated in patients with HCV ...

Hepatitis C is not spread through breast milk ... pegylated interferon (IFN), ribvirin (RBV), protease inhibitors such as boceprevir, telaprevir, simeprevir, and sofosbuvir and nucleotide polymer ...

If you have questions about taking Truvada with hepatitis C antiviral medications, talk with your doctor or pharmacist. Taking Truvada with certain protease inhibitor medications can raise your ...

hepatitis C virus; mRNA, messenger RNA; PI, protease inhibitor; NS, nonstructural protein; RdRp, RNA-dependent RNA polymerase; —, no drugs in this class in this phase of development.

Enanta has a long heritage in the development of antiviral compounds, working with AbbVie on therapies for hepatitis C virus (HCV ... pandemic focusing on 3CL protease – the same target as ...

In 1996, one of the first protease inhibitor drugs indicated ... serious health issues in the following six areas: hepatitis C virus, neuroscience, immunology, oncology, renal disease and women's ...

Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long ...

Hepatitis C, caused by hepatitis C virus (HCV), is a disease that can ... The cells were lysed with lysis buffer (Biosharp, BL504A) in the presence of protease inhibitor cocktail (87786, Thermo Fisher ...

Over 150 million people globally could unknowingly be carrying the highly infectious hepatitis C virus, which is often referred to as a 'silent killer' due to its slow progression and lack of ...